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ABSTRACT: Two-dimensional paper networks (2DPNs) have enabled the use of
paper-based platforms to perform multistep immunoassays for detection of
pathogenic diseases at the point-of-care. To date, however, detection has required
the user to provide multiple signal enhancement solutions and been limited to
protein targets. We solve these challenges by using mathematical equations to
guide the device design of a novel 2DPN, which leverages multiple fluidic inputs to
apply fully dried solutions of hydrogen peroxide, diaminobenzidine, and
horseradish peroxidase signal enhancement reagents to enhance the limit-of-
detection of numerous nucleic acid products. Upon rehydration in our unique
2DPN design, the dried signal enhancement solution reduces the limit-of-detection (LOD) of the device to 5 × 1011 nucleic acid
copies/mL without increasing false positive detection. Our easy-to-use device retains activity after 28 days of dry storage and
produces reliable signal enhancement 40 min after sample application. The fully integrated device demonstrated versatility in its
ability to detect double-stranded and single-stranded DNA samples, as well as peptide nucleic acids.
■ INTRODUCTION
While plate-based enzyme-linked immunosorbent assays
(ELISAs) or polymerase chain reaction (PCR) is still the
gold standard to detect viral pathogens,1−3 paper-based point-
of-care (POC) diagnostics have revolutionized global health
care by improving access and efficiency of these otherwise
complex laboratory assays. Lateral flow immunoassays
(LFIAs), which are single-channel microfluidic paper devices
that detect a pathogen antigen or host antibody response, have
miniaturized, automated, and simplified much of the diagnostic
process necessary for bacterial and viral pathogen detection.4
The low-cost, long-term stability, and ease-of-use of LFIAs
make them advantageous in low-resource settings.5,6 However,
LFIAs have limited sensitivity and POC accessibility due to the
inability to easily perform signal enhancement via multistep
assays. This is because the one-dimensional flow from a single
sample pad in LFIAs dictates that the user manually pipettes
each fluid sequentially at precisely timed intervals. The need to
perform more complex reactions has given rise to two-
dimensional paper networks (2DPNs), which typically consist
of more than one fluidic input and multiple carefully designed
channels to control fluid flow in the paper-based device.5,6
2DPNs have shown potential for conducting multistep assays
in the paper, such as amplifying nucleic acids,7 detecting more
than one target of interest,8 or enhancing the visual signal at
the detection zone compared to LFIA alone.9
Previous works have set a promising precedent by using
2DPNs as a platform to perform ELISAs for protein detection.
By tagging nucleic acid (NA) amplicons with proteins, ELISAs
have been translated for detection of NA samples for improved
signal clarity as well.5,7,10 Recent developments in chemical
ligation assays resulting in enzyme-free NA amplification and
CRISPR-based diagnostics have created exciting new molec-
ular platforms for rapid pathogenic detection at low-temper-
atures and have the potential for improved sensitivities at the
POC. However, many of these processes, including template-
assisted rapid assay (TARA), produce low product yields (102
amplicons of the initial target concentration) when compared
to loop-mediated isothermal amplification (LAMP) or PCR
(109 amplicons).11,12 To improve this, we have integrated an
ELISA into a 2DPN to provide secondary signal enhancement
in the detection zone. This enables us to maintain a high
sensitivity for these low-yield samples.
The design of a fully integrated 2DPN ELISA requires
optimization of the reagent delivery to improve performance
and produce reliable signal enhancement.13 Existing 2DPN
devices are categorized by the location of fluidic inputs: the
“leg” design, where reagent pads are placed at the far end of the
leg, which then extends and intersects with the main lateral
flow body (typically at a 90° angle),14 or the “linear” design,
where the reagent pads are placed directly on the main lateral
flow body.5 Previous 2DPN ELISAs required as many as five to
six fluid inputs with one or more wet reagents that had to be
prepared fresh.5,10 By analyzing these linear and leg designs
and performing mathematical modeling of capillary flow
through various nitrocellulose channel widths, we designed a
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device that utilizes a combination of the leg and linear design,
as well as a unique delay valve, to sequentially deliver reagents
to the detection zone for a fully automated 2DPN ELISA. This
enabled us to incorporate the enzymatic signal amplification
more effectively in our sequential flow, reduce the number and
volume of washes, and allow the user to add only a single
rehydrating buffer rather than storing and mixing refrigerated
reagents in the field.
Here, we present the development and integration of several
innovations that improve reagent flow and 2DPN usability, as
well as expand 2DPN applicability to detect nucleic acid
amplification products. Our device (Figure 1) builds upon the
previous literature to incorporate fully dried ELISA reagents:
horseradish peroxidase (HRP)-conjugated antibody label, its
colorimetric substrate diaminobenzidine (DAB), and redox
activator hydrogen peroxide (H2O2), which are all hydrated by
the application of a single solution: phosphate-buffered saline
with 0.05% Tween 20 (PBST). We utilize the high affinity of
streptavidin−biotin binding, protein conjugation to gold
nanoparticles (AuNPs), and ELISA-based signal enhancement
to optimize the signal output. By using AuNPs that are
conjugated with both streptavidin and HRP and incorporating
all reagents as dried source pads, we reduced the number of
fluidic inputs to four (one sample and three sites of buffer
addition), in comparison to six used in current paper-based
ELISAs.15 Our device demonstrates a limit-of-detection
(LOD) of 5 × 1011 NA copies/mL, which is comparable to
other RNA-based assays quantified in one-dimensional LFIAs
with an enhancement solution.16 Our platform can detect
single-stranded DNA (ssDNA), double-stranded DNA
(dsDNA), and peptide nucleic acid (PNA) samples at or
above this concentration. This platform is currently intended
for use with amplified NA samples tagged with carboxy-
fluorescein (FAM) and biotin and can be used to detect any
amplification product with these tags.
■ RESULTS AND DISCUSSION
Flow Parameter Change with Nitrocellulose Geome-
try. In hollow glass capillary channels, as studied in Berthier’s
capillary flow resistors,17 the surface tension is primarily
indicative of the physical properties of the fluid, and the
cohesion describes fluid interaction with the surrounding glass.
Nitrocellulose, however, is a porous membrane. As such, the
environment surrounding the fluid varies greatly and can
change depending on the geometry of the channel.
Our one-dimensional flow testing results (Table S3)
demonstrate that in nitrocellulose legs with very small widths,
as the width of the channel decreases, the apparent surface
tension of a solution containing DAB or AuNPs in nitro-
cellulose decreases. This is indicated by a channel width-
dependent change in the k parameter (defined in Computa-
tional Methods) for a given fluid. For example, AuNP flow
testing showed a decreasing trend of k = 230.3, k = 126.1, and
k = 75.2 for 5, 2, and 1 mm, respectively. A similar trend was
seen in DAB flow testing results, which had k values of 326.4,
137.2, and 52.76 for the 5, 2, and 1 mm channels, respectively.
As the width of the nitrocellulose channel decreases, a
reduction in the surface tension is observed. This indicates a
reduction in capillary pressure, and therefore a decrease in fluid
velocity in the channel. While these results contradict findings
from Berthier, they do agree with Dharmaraja et al.’s work,
which discusses the decreasing channel width as a method to
increase “resistance” of flow on wetted nitrocellulose when the
sequential flow is occurring.18 This more closely matches our
reagent delivery in the constructed 2DPN. The R2 values for
thinner channels (<5 mm) (Table S3) indicate flow that is less
consistent than in wider channels. This inconsistency was
particularly prevalent in the first 15 mm of the channels.
Optimizing 2DPN Flow. We made design choices based
on the results of our component characterizations and one-
dimensional flow tests (described in Experimental Methods).
The width of the main lateral flow channel for the AuNP-
bound sample solution was chosen to be 5 mm because it
produced the fastest and most consistent flow (Figure 2A).
The width of the signal enhancement leg for the DAB solution
was set at 2 mm (Figure 2B) because the fluidic resistance of
the smaller channel was designed to reduce the backflow of the
fluid from the main channel into the signal enhancement leg.
In initial experiments, when the fluid from the main channel
flowed back into the enhancement leg, reaction of SA−HRP−
AuNP-bound sample with the DAB began before sample
binding in the detection region. This resulted in reduced
sample binding at the detection zone and increase smearing or
background noise. We found the 2 mm channel alone was not
Figure 1. (A) Schematic of fully assembled 2DPN and location of dried reagent pads. (B) Target binding: fresh nucleic acid samples with
fluorescein isothiocyanate (FITC) and biotin tags applied to the dried SA−HRP−AuNP pad. Nucleic acid binding to SA−HRP−AuNPs occurs,
followed by capture at the test line in the main lateral flow channel. Unbound AuNPs bind to the biotin-tagged control line. Signal enhancement:
DAB and hydrogen peroxide solution flows from the signal enhancement leg to the main lateral flow channel and is oxidized by AuNP-bound poly-
HRP at test and control lines, producing a visually darkened (enhanced) signal.
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enough to prevent backflow. Therefore, we added a 5 μL
“delay valve”19 (2 × 5 mm2) near the intersection of the 2 mm
channel and the 5 mm channel. The capillary pressure exerted
by the saturation of the signal enhancement leg prevented the
backflow of the sample from the main channel.
A unique aspect of our design compared to the previous
literature is the location of the leg−channel intersection
downstream of the sample pad. Importantly, this allows us to
deliver the DAB and H2O2 upstream from the detection zone
but downstream from the sample pad to prevent premature
signal development and high background signal at the
detection zone. Additionally, the intersection is set at a 20°
angle from the main channel to ensure flow in only one
direction. Previously, inferior performance for leg devices was
reported due to parallel reagent delivery, which results in a
signal appearing only in the middle of the test zone.5 To ensure
this would not be a problem, we assessed the “clean delivery”
of each reagent. Clean delivery was defined as each model fluid
(food coloring) being delivered across a minimum of 90% of
the 5 mm channel width at the detection zone (Figure 2C).
We established that the DAB leg intersection must be a
minimum of 10 mm upstream of the detection zone for this
clean delivery to occur (Figure S4).
The length of the leg was chosen based on distance and time
results from flow testing to ensure that the DAB and H2O2
arrived at the detection zone after the sample and wash fluids.
The volume of the DAB and H2O2 pads was then adjusted to
compensate for the volume capacity of the nitrocellulose leg.
Similarly, sample and wash volumes were adjusted based on
the volume capacity of the nitrocellulose platform (Table S3).
Several innovations set this work apart from previous
2DPNs. We performed rigorous assessment of nine different
parameters of the device design to ensure optimal signal
development (Table S4). We did not use a final wash upstream
of the DAB because DAB does not require a “stop solution” to
arrest color development, unlike most other colorimetric
enhancement reactions including gold and silver enhancement
and tetramethylbenzidine (TMB).20 Additionally, reducing the
number of fluidic inputs also decreases the number of user
steps.
2DPN Flow Timing. Following one-dimensional flow
testing studies and 2DPN optimization, a food coloring timing
study was performed in the final, fully optimized nitrocellulose
design (Figure 2C). Based on the results of these flow studies,
the SA−HRP−AuNP-bound sample reached the detection
zone at approximately 5 min, followed by clean delivery of the
wash solution at the detection zone at 10 min. Therefore, the
pre-enhancement signal, occurring prior to DAB and H2O2
delivery, was defined as the signal intensity at 10 min. The
DAB and H2O2 signal enhancement solution arrived at the
detection zone at 25 min and produced a reliable signal
increase at 40 min. To allow time for the signal enhancement
reaction to complete, we measured the post-enhancement
signal at 60 min although amplification remained stable
between 40 and 90 min (Figure 3A). In the future, scaling
down the device size and liquid volumes could reduce some of
the total flow time. However, it is critical to ensure that the
unbound SA−HR−AuNPs are fully rinsed to prevent back-
ground noise from nonspecific signal development.
Signal Enhancement Stability Over Time. In Figure 3A,
our signal is above the visible threshold and maintains steady
contrast for consistent ease of reading at any time past the 40
min mark, up to our final measurement at 90 min. 2DPNs also
maintained this steady-state contrast several hours after testing
(not shown). Lathwal and Sikes have investigated a number of
enzymatic colorimetric enhancement agents for the improve-
ment of signal visualization on paper-based diagnostics.20 They
found that many common visualization agents did not retain
distinguishable positive or negative signals after 40 min and
that specifically timed reagent additions, wash steps, stop
solutions, and reading times would be necessary. A previous
study showed that the visible threshold for an untrained user
without instruction was quantified at 0.02 grayscale intensity
when normalized to the background using a custom MATLAB
program.21,22 Based on this, we used the 0.02 grayscale
intensity as the visible threshold for a positive result in our
experiments.
ELISA-Enhanced 2DPN Decreases LOD. In our experi-
ments, in which all components had been dried within the last
7 days, DAB signal enhancement improves the LOD from 1 ×
1012 to 5 × 1011 copies/mL (Figure 3C, replicates shown in
Figure S5). For 5 × 1011 copies/mL, the average AuNP signal
Figure 2. 2DPN flow optimization. (A, B) Experimental data (circles)
fit with eq 1 (line). k refers to the parameter from eq 1 and R2 is the
coefficient of determination for the fit of eq 1 to the data shown. (A)
AuNP solution velocity over distance in a 5 mm wide channel. (B)
DAB solution velocity over distance in a 2 mm wide channel. (C)
Proof-of-concept 2DPN flow with food coloring in PBST
demonstrating the sequential delivery of reagents to the detection
region (boxed).
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is 0.01, which is well below the 0.02 visible threshold, while the
average DAB-enhanced signal is 0.03. This LOD is comparable
to that of RNA-based assays in one-dimensional LFIAs with an
enhancement solution, which was found to be ∼1 × 1011
copies/mL.16 Figure 3B demonstrates the ability of our 2DPN
enhancement solution to increase the intensity of the test line
above the visible threshold when the AuNP signal alone was
not visible. Additionally, this visual enhancement does not
increase the visibility of a negative sample test line and does
not create false positives with negative (PBST only) samples.
Others have presented improvements in signal intensity and
visibility with viral detection platforms, but few have measured
the true change in LOD in terms of copies/mL. For example,
the Richards-Kortum group reports a visual signal increase of
15% with silver enhancement and 25% with gold enhance-
ment.16 We achieved an average 122% increase in signal
intensity for the dried 2DPN with our LOD sample of 25 μL
containing 5 × 1011 copies/mL ssDNA (Table S5). We
detected an average signal enhancement of 116% for all
samples above the LOD. Our device with signal enhancement
can detect sample concentrations 5 times smaller than our
device with AuNPs alone. Therefore, the signal enhancement
translates to a five-fold reduction in the LOD.
Signal Intensity Varies with Sample Concentration.
The signal output of the 2DPN showed test line intensity
changes as a function of sample concentration. The fit of the
ELISA (R2 = 0.9771) with our data indicates that our paper-
based dried reagent ELISA assay can generate results like that
of a traditional ELISA (Figure S7). This demonstrates the
potential of this paper diagnostic to quantitatively determine
sample loads, which is crucial for chronic disease monitoring
applications.
Reagents Retain Activity After 28 Days of Dry
Storage. Incorporating all necessary reagents predried on
the 2DPN improves ease-of-use by eliminating reagent
preparation steps. It also simplifies storing, packing, and
shipping of the devices, which is critical for the translation of
2DPNs into clinical use. Other researchers have dried different
individual components of the DAB/HRP/H2O2 reaction for
LFIAs and 2DPNs, but prior to this work, no one had
successfully demonstrated and measured LOD improvements
of all components in a dry state.5,10
We tested the ability to dry and store all reagents to
determine the practicality of this device for real-world use.
After drying, assembling, and storing all components of the
2DPN device for 1, 7, and 28 days, we still observed similarly
detectable signals. There were no statistically significant
decreases in the signal intensity after 7 or 28 days of dry
storage for a sample concentration of 5 × 1012 dsDNA copies/
mL (hybridized probes 1 and 2, Table S1). Although the high
concentration sample of 1 × 1014 copies/mL on the 2DPN did
show a significant decrease in signal intensity after 28 days, the
intensity remained well above the visible threshold (Figure 4).
These results show that our dried SA−HRP−AuNPs, DAB,
and H2O2 retained activity for at least 28 days of dry storage on
a fully assembled device. Because signal intensity at lower
sample concentrations did not significantly degrade, we
conclude that the sensitivity of our device is the same before
and after 28 days of storage. In the future, lower sample
concentrations and devices older than 28 days can be tested to
establish the LOD of dried 2DPNs after long-term storage.
2DPNs Detect Amplified MERS-CoV TARA Products.
To extend the application of our device beyond the detection
of a model probe, we tested diluted TARA product on our
Figure 3. Signal development over time. (A) Signal intensity of the
test line over time for 5 × 1012 and 5 × 1011 copies of ssDNA/mL.
Dashed lines indicate time points when the AuNP signal and the
DAB-enhanced signal data are compared. (B) Detection region of
2DPN imaged at 10 min (AuNP signal) and at 60 min (DAB-
enhanced signal). (C) Normalized test line intensities at 10 min
(AuNP signal) and at 60 min (DAB-enhanced signal) for varying
ssDNA concentrations. The visible threshold at 0.02 is indicated by a
dashed line. (Dunnett’s multiple comparison vs 0 copies/mL, *p <
0.05, ***p < 0.001, ****p < 0.0001, n = 3, replicates shown in Figure
S5).
Figure 4. Quantification of test line intensity. Background-subtracted
grayscale test line intensity for hybridized DNA samples run on fully
dried and assembled 2DPNs imaged after 60 min. The visible
threshold at 0.02 is indicated by a dashed line. (n = 6, **p < 0.01 in
Dunnett’s multiple comparison with 1 day dried storage 2DPN as the
control).
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dried 2DPN (Figure 5A, replicates shown in Figure S6). The
TARA reaction can produce detectable PNA strands at a
concentration ∼100× higher than the initial target RNA
concentration at room temperature in as little as 15 min.11 The
average background-subtracted grayscale signal produced by
the TARA-amplified sample (10× diluted) after 60 min on the
dried 2DPN was 0.08 (Figure 5B). Based on the ELISA
calibration curve, this translates to a sample concentration of
2.7 × 1012 copies/mL (eq 2, Figure S7). Given that 2 × 1011
copies/mL of target RNA was input into the TARA reaction
and the TARA reaction was diluted 1:10, the estimated
concentration of the TARA-amplified sample was 2.7 × 1013
copies/mL. This confirms that TARA amplifies concentrations
∼100-fold.
Based on these results, combining TARA and 2DPN
technologies could result in a LOD as low as 5 × 109
copies/mL. Clinical samples from lower respiratory samples
(aspirate) of MERS-CoV-infected patients had a mean virus
concentration/mL of 5.0 × 106 (maximum 6.3 × 1010).23 With
a combination of TARA and our 2DPN, we could detect
samples in the upper range of clinically relevant concentrations
without the need for heating or multiple pipetting steps. Test
results can be produced within as little as 1 h (based on a 15
min amplification, 5 min sample and reagent application, and
40 min of signal enhancement on the 2DPN). Further
optimization or increased amplification time of the TARA
reaction and additional characterization of the AuNP−SA−
HRP signal enhancement is feasible to further improve overall
LOD. Specifically, the amount of signal enhancement on the
2DPN can be further improved by characterizing the HRP
reagent, as the protein used in this assay was a preconjugated,
proprietary SA−HRP product with an unspecified amount of
HRP molecules attached.
We calculated the cost of materials for this platform, as seen
in Table S6. We estimate that the total cost of goods for our
2DPN is approximately 1.82 USD. Commercially available
one-dimensional LFIAs with an anti-FITC test line and a
biotin control are available from 3.75 USD.24 Reported cost
estimate calculations for other lab-based LFIAs for viral
detection platforms to range from 0.8016 to 12.7025 USD.
While the general cost of materials for any platform should be
considered for theoretical commercial translation, over-reliance
on cost reduction as a feature of POC designs without
consideration of other cost factors is an issue we do not want
to promote.26 While this platform is considered of low cost
from a material perspective, we recognize that significant
manufacturing costs may be a barrier to commercialization.
Although the assembly of 2DPNs is not as straightforward as
that of one-dimensional LFIAs, we anticipate that robotic
advancements such as pick-n-place, cut-sheet manufacturing,
and roll-to-roll will enable scale-up of devices.
■ CONCLUSIONS
We have demonstrated a 2DPN design that automates the flow
of a signal enhancement solution to improve the LOD of
nucleic acid samples labeled with FITC and biotin. We
improved upon previous 2DPN designs that use DAB as a
signal enhancer by reducing the number of fluidic inputs and
detection time and by incorporating dry storage of all
necessary reagents, including a source for reactive hydrogen
peroxide. Our fully dried device has shown versatility in the
ability to detect multiple types of nucleic acid samples,
including PNA products from a room-temperature RNA
amplification reaction, TARA. The applicability of this 2DPN
can be extended to detect a variety of pathogens and
incorporate other amplification reactions with FITC and
biotin-tagged products. The HRP signal enhancement retains
activity after 28 days of dry storage on a fully assembled device.
The fully dried and assembled device (after a total of 60 min
run time) achieved a LOD of 5 × 1011 copies of ssDNA per
mL, comparable to other hybridization-based nucleic acid
detection devices. When combined with TARA, the LOD can
reach as low as 5 × 109 target copies/mL and can be further
reduced by using other NA amplification methods with higher
outputs. The signal in the detection zone is maintained well
after the sample is run, reducing the need for the strictly timed
reading of results.
These critical advancements enable sample detection and
enhancement of amplified NA products with an average signal
enhancement of 116% for samples above the LOD. Our 2DPN
produces a signal intensity increase much greater than
commercially available gold or silver enhancement solutions
and requires only simple rehydration of pads and folding to
perform. We determined not only the increase in signal
intensity but also how that increase affects the true LOD (in
copies/mL), a practice we believe should be applied to the
design of all LFIAs incorporating signal enhancement agents.
This proof-of-concept for a fully dried, deployable 2DPN
shows promise for detecting many other pathogens beyond
Mers-CoV and can be employed with other nucleic acid
amplification techniques. Our fully dried, automated viral
detection platform has shown to be a successful proof-of-
concept with multiple types of NA samples. These results are
promising for the future applications of this technology at the
POC.
Figure 5. Results of TARA sample (1:10 dilution in PBST) on a dried
2DPN. (A) Scans taken of a representative test at 10 and 60 min. (B)
Test line signal intensity analysis of the TARA sample on 2DPNs
before and after signal enhancement (paired t-test, *p < 0.05, n = 3,
replicates shown in Figure S6).
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://dx.doi.org/10.1021/acsomega.0c00115
ACS Omega 2020, 5, 4673−4681
4677
■ COMPUTATIONAL METHODS
To characterize capillary flow parameters necessary to establish
channel widths and lengths in our 2DPN, we evaluated and
modeled one-dimensional flow rates using an extension of the
Lucas−Washburn and Darcy equations as previously demon-
strated by Gosselin et al.27 The flow rate of each of the
reagents was analyzed using mathematical models for capillary
pressure. Capillary pressure (Pc) in a rectangular channel is
described by the equation
γ θ θ γ θ θ= + + +P h w(cos( ) cos( ))/ (cos( ) cos( ))/a b c dc
where γ is the surface tension, θi is the contact angle of fluid on
each i surface, h is the height of the membrane, and w is the
width of the membrane.28 If we assume a rectangular cross-
section of nitrocellulose and that particles are diluted in water,
then Pc = γ(2 cos (θ)/h + 2 cos (θ)/w), where every surface i is
nitrocellulose and θ is the advancing contact angle of pure
water on nitrocellulose. Given that our nitrocellulose
membrane, FF80HP (GE Healthcare), has pore size
comparable to HF135 (Millipore),21 which can pass particles
of up to 0.5 μm,29 we can assume an approximate pore size of
0.5 μm. For water on 0.45 μm pore size nitrocellulose, the
advancing contact angle is measured to be approximately
40°.30 The capillary force is then equal to Fcap = Pc × hw.
Substituting in the expression for Pc, the equation becomes Fcap
= γ2 cos (θ) (w + h). Due to the low Reynold’s numbers in
small capillary channels, the inertial effects can be neglected,
and the capillary force can be equated to the drag force Fdrag =
6μVzC,27 where μ is the viscosity of the fluid, V is the velocity,
z is the distance traveled in the capillary channel, and C is the
geometric constant: C = 2h/w + w/h. Then, 6μVzC =
γ2 cos (θ) (w + h). Then, rearranging to solve for velocity gives




where nitrocellulose width (w) and height (h) are maintained
and k is defined as γ/μ and is determined experimentally for
DAB and AuNP solutions.
■ EXPERIMENTAL METHODS
Reagents and Materials. Reagents used throughout this
work include PBST (0.05% Tween 20, Millipore Sigma, Inc.,
Burlington, MA), 40 kDa poly(vinylpyrrolidone) (PVP40)
(Millipore Sigma, Inc., Burlington, MA), fraction V bovine
serum albumin (BSA) (Biotium, Fremont, CA), sucrose (IBI
Scientific, Dubuque, IA), poly(ethylene glycol) (PEG) (MW
3350 Da, 0.2% w/v), trehalose (Thermo Fisher Scientific, NJ),
FeSO4-EDTA (Fe-EDTA) (Millipore Sigma, Inc.), and
molecular biology water (Thermo Fisher Scientific). DAB
and urea hydrogen peroxide SigmaFast tablets (#D4168,
Millipore Sigma, Inc.) were rehydrated according to product
specifications for initial dried enzymatic signal testing. For
long-term storage tests, hydrogen peroxide urea-adduct
(#95314-250G, Millipore Sigma, Inc.,) tablets were crushed
into a powder.
Streptavidin poly-HRP (SA−HRP, #21140, Pierce Bio-
technology, Rockford, IL) and 40 nm AuNPs (G-40-100,
Cytodiagnostics Inc., Burlington, ON) for SA−HRP−AuNP
conjugation (SA−HRP−AuNPs). Polyclonal goat anti-rabbit
biotin conjugate (#31822, Thermo Fisher Scientific). A
monoclonal anti-FITC antibody (1F8-1E4, Invitrogen, Rock-
ford, IL) was used for long-term dry storage tests. Due to
product changes and subsequent lack of binding for different
lot numbers, we switched antibodies and used polyclonal anti-
FITC antibody (20C-CR1056SP, Fitzgerald, Bath BA1 1BE,
U.K.) for LOD dried tests and for the remainder of the
investigation. All oligonucleotide probes were custom-ordered
from IDT (Integrated DNA Technologies, Inc., Coralville, IA).
Food coloring for one-dimensional flow testing (McCormick
Assorted Food Color & Egg Dye).
2DPN materials for fabrication and storage include nitro-
cellulose (FF80HP) and the cellulose absorbent pad (#3001-
861) from GE Healthcare Bio-Science Corp. (Pittsburgh, PA),
Grafix Dura-Lar Clear Adhesive-Backed Film (Dick Blick Art
Materials, Galesburg, IL), glass fiber reagent storage pads
(#GFCP103000, Millipore Sigma, Inc.), and silica gel desiccant
(S-3903, ULINE, Pleasant Prairie, WI).
Characterization of LFIA Components. The volume
capacity of the nitrocellulose membrane and the glass fiber
conjugate pads was calculated by determining the dry mass of
the membrane using a ME-T Analytical Balance (Mettler
Toledo), submerging the membrane in deionized (DI) water
for 2 min, and then determining the wet mass of the
membrane. Using the density of water, the total volume held
by the membrane segment was calculated and divided by the
area of the segment. The volume released from the glass fiber
pads was estimated by first measuring the wet mass of the
membrane. Then, the membrane was placed on nitrocellulose
with a 2 mm overlap and covered with adhesive. The post-flow
mass was measured after leaving the wet membrane in contact
with nitrocellulose for 20 min. The volume released is
expressed as a percentage difference of post-flow mass and
wet mass relative to the initial wet mass.
Flow Rate Analysis. One-dimensional flow studies were
performed with reagents in nitrocellulose channels of varying
width. Linear nitrocellulose patterns were designed in Adobe
Illustrator CS6. Designs were 50 mm long with a width of
either 1, 2, or 5 mm and included a fluid collection segment at
the end with an area of 100 mm2. The nitrocellulose patterns
were cut from with a Silhouette Cameo 3 cutter (Silhouette
America, Inc., Lindon, UT). The nitrocellulose was blocked
with a solution of 0.25% PVP40, 2% BSA, and 5% sucrose in
PBST to prevent nonspecific binding.31 The volume used in
each test was adjusted for the nitrocellulose and glass fiber pad
volume capacity. The sample of conjugated AuNPs or prepared
DAB was applied to the source pad. The flow was video-
recorded with an iPhone 6 at 30 frames per second with a 5
mm reference length in the frame until the fluid front reached
the fluid collection segment. The distance and time measure-
ments were plotted at the location of the fluid front for each
frame in the video. The average velocity was calculated over 5 s
intervals. The velocity vs distance graphs were fit with a
nonlinear curve of eq 1 using the least-squares method to find
the parameter k using GraphPad Prism v8. We assumed that
dynamic viscosity (μ) is constant for each fluid. Therefore, we
interpret a change in the k value as a change in surface tension
(γ), as surface tension is dependent on the surrounding
environment, as well as the properties of the fluid.
2DPN Assembly. We created the 2DPN design in the
Adobe Illustrator software (CS6, Adobe Inc., San Jose, CA).
Nitrocellulose and adhesive patterns were laser cut with a
VLS3.50 laser cutter (Universal Laser Systems Inc., Scottsdale,
AZ). Adhesive patterns were cut from Dura-Lar Clear
Adhesive. Goat anti-rabbit biotin conjugate (0.2−0.4 μL of
1.3 mg/mL) was pipetted onto the nitrocellulose for the
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control line. Anti-FTIC antibody (0.2−0.4 μL of 1.5 mg/mL)
was pipetted onto the nitrocellulose for the test line. Glass fiber
pads and the cellulose waste pad were hand cut. The 2DPN
components were assembled on the adhesive backing, as
shown in Figure 1A. 2DPN storage conditions are shown in
Figure S1.
Drying of Reagents. For the dried components of the
AuNP signal and subsequent enzymatic enhancement, we
employed specific methods proven by the previous literature to
maintain the stability of each reagent. SA−HRP was added to
each 1 mL of 1 optical density (OD) 40 nm AuNPs for a final
SA−HRP concentration of 0.01 mg/mL. The solution was
incubated on a rocker for 30 min at room temperature. The
solution was blocked with the BSA Fraction V (1% w/v) for 1
h at room temperature followed by blocking with PEG (0.2%
w/v) for 1 h at room temperature. The AuNPs were
centrifuged at 900×g for 30 min. The supernatant was
discarded, preserving the AuNP pellet. The pellet was
resuspended in drying buffer (0.5× PBS, pH 7.4, 10% sucrose,
1% Tween 20, 0.5% BSA Fraction V, 0.2% PEG, 0.5% PVP40),
and the OD was measured using a NanoDrop 2000c (Thermo
Fisher Scientific). OD was adjusted by diluting conjugated
AuNPs with drying buffer. Trehalose (4% w/v) and 0.01 M Fe-
EDTA were added prior to drying. Twenty five microliters of
the conjugated SA−HRP−AuNP solution was then deposited
on an 8 × 5 mm2 glass fiber pad and dried under vacuum with
a desiccant at room temperature overnight.
To prepare dry DAB pads, one DAB tablet was rehydrated
in 500 μL of PBST, for a concentration of 1.4 mg/mL.
Trehalose (4% w/v) was added to the DAB solution.10 Fifty
microliters of DAB solution was deposited on an 8 × 10 mm2
glass fiber pad, then dried under vacuum at room temperature
overnight. H2O2 tablets were crushed into a powder, and 2 mg
of the tablet powder was affixed on the adhesive under a 50 μL
capacity glass fiber pad.
Design of the Model DNA Probe. To create a hybridized
double-stranded DNA (dsDNA) model, 1 μL of 100 μM of 6-
carboxyfluorescein (FAM)-tagged ssDNA (Table S1, probe 1),
1 μL of 100 μM of biotin-tagged ssDNA (Table S1, probe 2),
10 μL of 10× isothermal amplification buffer I, and 88 μL of
DNase/RNase free water were combined in a small PCR tube.
The PCR tube was placed in a thermocycler and run on a
protocol of 95 °C for 1 min followed by 25 °C for 1 min, for a
total of 20 min. The concentration of the probe was
determined using a NanoDrop 2000c (50 ng/μL per 1 OD).
The hybridized dsDNA probe was stored at −20 °C until use.
Single-stranded DNA (ssDNA) tagged with both FAM and
biotin (Table S1, probe 3), provided by IDT, was used as the
ssDNA model.
Running the 2DPN. Volumes were loaded onto the 2DPN
as follows: 25 μL of the NA sample onto pad (1), 25 μL PBST
onto pad (2), 5 μL PBST onto pad (3), and 50 μL PBST onto
pad (4) (Figure 1A). Then, the device was folded at the crease
to initiate flow through the channels and sealed around the
edges. Devices were imaged every 5 min using a flatbed
scanner (V850 Pro, Epson America, Inc., Long Beach, CA) at
1200 dpi. For flow visualization, food coloring was added to
PBST and deposited on the glass fiber pads. Test and control
line intensities were analyzed with a custom MATLAB
script.21,22 The visible threshold (the visual cutoff for
interpreting a test line as positive) of the background
normalized grayscale intensity was set to 0.02 for all signal
analyses according to Phillips et al.22
For LOD tests, dilutions of 100 μM probe 3 solution in
PBST were used. Tests were run on assembled 2DPNs stored
between 1 and 7 days. ssDNA was used in the LOD tests
because the exact concentration is provided by the
manufacturer. NanoDrop measurements of dsDNA-hybridized
probe concentration provide an approximate concentration but
cannot provide information on the amount that hybridized
compared to remaining nonhybridized strands. The previous
analysis of dried 2DPN results tested with comparable
concentrations of ssDNA and dsDNA probes showed no
significant differences in intensity (not shown). For storage
tests, a dsDNA-hybridized probe sample was diluted in PBST
to approximate concentrations of 1 × 1014 and 5 × 1012
copies/mL. The same dsDNA samples were used in all 1-, 7-,
and 28-day storage tests. For both LOD and storage tests,
replicates for any given sample concentration and device
condition were performed simultaneously.
ELISA Standard Curve. Four-parameter logistic (4PL)
models are typically used to model signal intensity as a
function of sample concentration in ligand-binding assays, such
as ELISAs.32 Therefore, we selected this model to evaluate our






1 10 c x b( ) (2)
where y is the signal intensity, x is the log of sample
concentration, a is the response at 0 concentration, d is the
response at infinite concentration, c is the concentration that
gives a signal intensity halfway between a and d, and b is a
slope parameter typically near 1.33 The 4PL model was fit to
the LOD data in GraphPad Prism v8 with the slope parameter
(b) constrained to 1.
Template-Assisted Rapid Assay (TARA). TARA is a
proprietary RNA amplification technology developed by
CrossLife Technologies Inc.11 TARA is an enzyme-free
chemical ligation assay that leverages a target RNA sequence
to initiate hybridization of a peptide nucleic acid (PNA)
backbone containing FAM to a second PNA strand containing
biotin. This results in a single PNA strand with both markers
(Figure S2). PNA probes to detect the nucleocapsid gene of
MERS-CoV were designed using the Applied Biosystems
Primer Express v2 software (structure and sequence details
shown in Figure S3 and Table S2). Probe hybridization
sequences were evaluated by the Basic Local Alignment Search
Tool (BLAST) to select regions conserved across multiple
transcript variants. For the initial design, target complexity and
accessibility were evaluated using Visual OMP (DNA Software
Inc., Ann Arbor, MI). PNAs were synthesized by PNAbio Inc.
(Thousand Oaks, CA). ssRNA at an initial concentration of 2.0
× 1011 copies/mL was purchased from IDT. TARA was
performed with the ssRNA at room temperature for 15 min.
Dilutions of final TARA products were made in PBST and
applied directly to sample pads on 2DPNs that had been dried
and assembled within the previous 7 days. The same diluted
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